From the Laboratory to the Land: New discoveries in cancer

Have you ever wondered how prescription drugs make it from the manufacturer to the marketplace? On today’s show, we’re going to take detailed look at the drug review and approval process in the United States and compare our system with other countries’. We’ll also reveal what’s coming down the pipeline in terms of new innovations in cancer treatment. Guests include Kenneth Miller, MD, Assistant Professor of Medicine at Yale School of Medicine in the Section of Medical Oncology, and Director of the Connecticut Challenge Survivorship Clinic and the Supportive Care Program at Yale Cancer Center; and Garo Armen, PhD, Chairman and CEO of Antigenics, Inc.